The analysis of 161 tumor tissues and 126 NATs from the UKB cohort confirmed PD-L2 hypomethylation in tumors compared to NATs (median methylation in tumors: 4.42%, NATs: 8.32%, p < 0.001, Mann–Whitney U test, Figure 2). The gene discussed is PDCD1LG2; the disease is neoplasm.